Determination of the main bioactive metabolites of Radix Salvia miltiorrhizae in Compound Danshen Dripping Pills and the tissue distribution of Danshensu in rabbit by SPE-HPLC-MSn

Journal of Separation Science

Volumn 30, Issue 6, 2007, Pages 851-857

  Xiaohui, Zheng ^a,b,c   Xinfeng, Zhao ^b   Xin, Zhao ^b   Shixiang, Wang ^a   Yinmao, Wei ^a   Jianbin, Zheng ^a  

^a NORTHWEST UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c NONE   (China)

Author keywords

Compound Danshen Dripping Pills; Danshensu; Salvia miltiorrhiza

Indexed keywords

ION TRAP MASS SPECTROMETRY; SOLID PHASE EXTRACTION;

EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEDICINE; METABOLITES; TISSUE;

BIOTECHNOLOGY;

2 HYDROXYL 3 (3,4 DIHYDROXYPHENYL)PROPRIONIC SULFURIC ANHYDRIDE; 3 (3,4 DIHYDROXYPHENYL) 2 HYDROXYPROPIONIC ACID; BORNEOLUM SYNTHETICUM EXTRACT; CATECHOL; COMPOUND DANSHEN DRIPPING PILL; DRUG METABOLITE; ISOPROPYL 3 (3,4 DIHYDROXYPHENYL) 2 HYDROXYPROPANOATE; PANAX NOTOGINSENG EXTRACT; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; PROPIONIC ACID DERIVATIVE; SALVIA MILTIORRHIZA EXTRACT; UNCLASSIFIED DRUG; VANILLIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; HEART; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; KIDNEY; LUNG; MASS SPECTROMETRY; NONHUMAN; PILL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RABBIT; SOLID PHASE EXTRACTION; TISSUE DISTRIBUTION; VALIDATION PROCESS; VASODILATATION;

ANIMALS; CATECHOLS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; DRUGS, CHINESE HERBAL; FEMALE; LACTATES; MALE; MESENTERIC ARTERIES; MOLECULAR STRUCTURE; PLANT ROOTS; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; SALVIA MILTIORRHIZA; SOLID PHASE EXTRACTION; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TISSUE DISTRIBUTION; VANILLIC ACID; VASODILATOR AGENTS;

ORYCTOLAGUS CUNICULUS; SALVIA MILTIORRHIZA;

EID: 34248393877     PISSN: 16159306     EISSN: 16159314     Source Type: Journal    
DOI: 10.1002/jssc.200600287     Document Type: Article

References (16)

1. Editorial Committee of the Pharmacopoeia of the People's Republic of China, Pharmacopoeia of the People's Republic of China (First Part) [S], Chemical Industry Press, Beijing 1995.
2. Chen, H., Chen, F., Zhang, Y. L., Song, J. Y., Process Biochem. 1999, 34, 777-784.
3. Chan, K., Chui, S. H., Wong, D. Y. L., Ha, W. Y., et al., Life Sci. 2004, 75, 3157-3171.
4. Huang, T. L., Wang, N. S., Trad. Chin. Drug Res. Clinic. Pharmacol. 2001, 12, 354-358.
5. Ji, X. Y., Tan, B. K. H., Zhu, Y. C., Linz, W., Zhu, Y. Z., Life Sci. 2003, 73, 1413-1426.
6. Lay, I. S., Hsieh, C. C., Chiu, J. H., Shiao, M. S., et al., J. Surg. Res. 2003, 115, 279-285.
7. Li, H. B., Lai, J. P., Jiang, Y., Chen, F., J. Chromatogr. A 2002, 943, 235-239.
8. Ding, M., Ye, T. X., Zhao, G. R., Yuan, Y. J., Guo, Z. X., Int. Immunopharmacol. 2005, 5, 1641-1651.
9. Takahashi, K., OuYang, X., Komatsu, K., Nakamura, N., et al., Biomed. Pharmacol. 2002, 64, 745-750.
10. Wang, X. H., Xu, J. X., Neurosci. Res. 2001, 51, 129-138.
11. Liu, A. H., Li, L., Xu, M., Lin, Y. H., et al., J. Pharmaceut. Biomed. 2006, 41, 48-56.
12. Zhao, Y., Chen, B., Yao, S. Z., J. Pharmaceut. Biomed. 2005, 38, 564-570.
13. Wang, N. S., Mi, S. Q., Hong, X., Trad. Chin. Drug Res. Clinic. Pharmacol. 2000, 11, 141-145.
14. Hong, X., Mi, S. Q., Wang, N. S., Trad. Chin. Drug Res. Clinic. Pharmacol. 2000, 11, 286-288.
15. Zheng, X. H., Zhang, Y. C., Wang, S. X., Zhao, X. F., Chinese Patent 200410026205.3.2004, 10.
16. Zhang, J. L., Cao, Y. X., Xu, C. B., Lars, E., BMC Cardiovasc. Disord. 2006, in press.